This enduring program focuses on enhancing clinicians’ ability to screen and identify early-stage type 1 diabetes (T1D). In addition, the program will overview T1D screening criteria, follow-up after screening results, and communicating effectively with patients to guide timely treatment decisions. Learners will also explore evidence-based criteria for selecting appropriate candidates for T1D disease-modifying therapies, implementing protocols to ensure their safe and efficient administration, as well as how to appropriately refer to specialty care to enable their earlier use.
RELEASED DATE: September 18, 2025
EXPIRATION DATE: September 18, 2026